3,796 results match your criteria Pityriasis

Pityriasis rosea, human herpesvirus 6 infection and pregnancy.

J Med Virol 2022 May 12. Epub 2022 May 12.

Dermatology Unit, Ospedale Policlinico San Martino, Largo R. Benzi, 10, 16132, Genoa, Italy.

we read the interesting article by Bortolotti et al. on the relationship between human herpesvirus 6 (HHV-6) infection and intrauterine growth restriction (IUGR) that prompted us to describe our experience about pityriasis rosea (PR) occurring during pregnancy. This article is protected by copyright. Read More

View Article and Full-Text PDF

Longitudinal course and predictors of depressive symptoms in atopic dermatitis.

J Am Acad Dermatol 2022 May 9. Epub 2022 May 9.

Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC USA.

Background: Atopic dermatitis (AD) is associated with eczematous lesions, pruritus, pain, and sleep disturbance, which may negatively impact mental health over time.

Objective: Determine the predictors and longitudinal course of depressive symptoms in adults with AD.

Methods: A prospective, dermatology practice-based study was performed (n=695). Read More

View Article and Full-Text PDF

Erythrodermic pityriasis rubra pilaris after SASRS-CoV-2 vaccination with concomitant COVID-19 infection.

J Eur Acad Dermatol Venereol 2022 May 10. Epub 2022 May 10.

Department of Dermatology, Christian Hospital Unna, Unna, Germany.

View Article and Full-Text PDF

Pityriasis Rosea and Pityriasis Rosea-Like Eruptions after COVID-19 vaccines.

JAAD Int 2022 May 3. Epub 2022 May 3.

Dermatology Unit, San Martino Hospital, Largo R. Benzi, 10, 16132, Genoa, Italy.

View Article and Full-Text PDF

Inverse pityriasis rosea secondary to COVID-19 vaccination.

Proc (Bayl Univ Med Cent) 2022 9;35(3):342-343. Epub 2022 Mar 9.

Department of Dermatology, Texas Tech University Health Sciences Center, Lubbock, Texas.

A 56-year-old woman presented for evaluation of a pruritic rash with associated body aches, fever, and chills that first appeared about 1 week after Johnson and Johnson COVID-19 vaccination. The rash initially presented as one lesion on her left breast that then spread to her face and groin. Based on clinical presentation, dermoscopic findings, and histopathological examination, a diagnosis of inverse pityriasis rosea was made. Read More

View Article and Full-Text PDF

Effectiveness of FastFung agar in the isolation of Malassezia furfur from skin samples.

Mycoses 2022 May 4. Epub 2022 May 4.

Cukurova University, Medical Faculty, Department of Medical Microbiology, Adana, Turkey.

Background: Lipophilic basidiomycetous yeasts of the Malassezia genus can cause various skin diseases, such as seborrheic dermatitis, pityriasis versicolor, folliculitis and atopic dermatitis, and even life-threatening fungemia in newborns and immunocompromised individuals. Routine mycological media used in clinical practice do not contain sufficient lipid ingredients required for the growth of Malassezia species. A recently developed medium, FastFung agar, is promising for culturing fastidious fungal species. Read More

View Article and Full-Text PDF

Olmsted Syndrome With Follicular Hyperkeratosis and Pityriasis Amiantacea.

Actas Dermosifiliogr 2022 Apr 28. Epub 2022 Apr 28.

Assistant Professor, Department of Pathology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, India.

View Article and Full-Text PDF

Pityriasis rubra pilaris potentially triggered by messenger RNA-1273 COVID vaccine.

JAAD Case Rep 2022 May 1;23:114-116. Epub 2022 Apr 1.

Department of Dermatology, Medical College of Georgia, Augusta University, Augusta, Georgia.

View Article and Full-Text PDF

A case of classic adult pityriasis rubra pilaris successfully treated with a combination of acitretin and ustekinumab: A case report.

SAGE Open Med Case Rep 2022 19;10:2050313X221093453. Epub 2022 Apr 19.

Division of Dermatology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.

Classic adult pityriasis rubra pilaris is a severe papulosquamous disease that tends to resolve in 3-5 years but can have a devastating impact on patients while active. It shares features with psoriasis, but treatment remains largely empiric, based on case reports and series. The condition is often refractory to treatment, especially initially, with topical corticosteroids and oral acitretin the more commonly employed agents. Read More

View Article and Full-Text PDF

Parapsoriasis-A Diagnosis with an Identity Crisis: A Narrative Review.

Dermatol Ther (Heidelb) 2022 May 15;12(5):1091-1102. Epub 2022 Apr 15.

Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA, 19104, USA.

Parapsoriasis is an uncommon inflammatory skin disease characterized by chronic patches that may be resistant to therapy. It was primarily introduced and classified 120 years ago, and the original classification incorporated parapsoriasis and pityriasis lichenoides under the umbrella term parapsoriasis. After a major change in classification, parapsoriasis now exclusively refers to small plaque parapsoriasis (SPP) and large plaque parapsoriasis (LPP). Read More

View Article and Full-Text PDF

Domperidone-induced pityriasis rosea-like drug eruption.

Clin Case Rep 2022 Apr 5;10(4):e05674. Epub 2022 Apr 5.

Department of Dermatology Farhat Hached university hospital Sousse Tunisia.

Pityriasis rosea is a common, acute, self limiting inflammatory skin disease. Pityriasis rosea-like eruptions (PR-LE) have been reported after drugs. The clinical presentation of PR-LE can be distinguished from pityriasis rosea. Read More

View Article and Full-Text PDF

Drug-induced pityriasis lichenoides from infliximab in a patient with juvenile idiopathic arthritis.

JAAD Case Rep 2022 May 2;23:55-57. Epub 2022 Mar 2.

University of South Carolina School of Medicine, Greenville, South Carolina.

View Article and Full-Text PDF

Facial demodicosis in the immunosuppressed state: a retrospective case series from a tertiary referral center.

Int J Dermatol 2022 Apr 10. Epub 2022 Apr 10.

Division of Dermatology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.

Background: Data on Demodex in the immunosuppressed state is limited, focusing mainly on patients with human immunodeficiency virus and hematological malignancies. The aim of this study was to describe the manifestations of facial demodicosis in diverse immunosuppressive states.

Methods: The medical records of all patients followed at a Demodex outpatient clinic of a tertiary medical center from January 2008 to November 2020 were retrospectively reviewed. Read More

View Article and Full-Text PDF

Lepromatous leprosy with dermatofibroma features: colonization or morphological variant of histoid leprosy with epidermal induction?

Int J Dermatol 2022 Mar 29. Epub 2022 Mar 29.

School of Medicine, Botucatu Medical School, Paulista State University (UNESP), Botucatu, São Paulo, Brazil.

Background: Leprosy is one of the main health problems in developing countries. It can show many different clinical presentations.

Case Report: A 37-yr-old woman with multiple reddish-brown papules on the lower and upper limbs, including the palms. Read More

View Article and Full-Text PDF

Demodicosis Imitating Acne Vulgaris: A Case Report.

Clin Cosmet Investig Dermatol 2022 19;15:497-501. Epub 2022 Mar 19.

School of Anti-Aging and Regenerative Medicine, Mae Fah Luang University, Bangkok, 10110, Thailand.

Demodicosis is caused by mite infestation and can present with a variety of clinical manifestations, including pityriasis folliculorum type, rosacea-like type, folliculitis-like type and perioral dermatitis-like type. Therefore, this skin condition is often misdiagnosed or underdiagnosed. This report presents a 19-year-old woman with a history of pityriasis folliculorum type demodicosis and successful treatment with oral ivermectin. Read More

View Article and Full-Text PDF

Acute postinfectious type III pityriasis rubra pilaris as a cutaneous manifestation in COVID-19: Decoding a possible trigger!!

J Cosmet Dermatol 2022 Mar 25. Epub 2022 Mar 25.

Department of Dermatology, Venereology and Leprology, Sardar Patel Medical College, Bikaner, Rajasthan, India.

View Article and Full-Text PDF

Thiol-Disulfide Homeostasis in Skin Diseases.

J Clin Med 2022 Mar 9;11(6). Epub 2022 Mar 9.

Department of Dermatology, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.

Oxidative stress represents the imbalance between oxidants and antioxidants and has been associated with a wide range of diseases. Thiols are the most important compounds in antioxidant defense. There is an equilibrium between thiols and their oxidized forms, disulfides, known as dynamic thiol-disulfide homeostasis (TDH). Read More

View Article and Full-Text PDF

A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders.

Dermatol Ther 2022 Mar 22:e15461. Epub 2022 Mar 22.

Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

With dermatologic side effects being fairly prevalent following vaccination against COVID-19, and the multitude of studies aiming to report and analyze these adverse events, the need for an extensive investigation on previous studies seemed urgent, in order to provide a thorough body of information about these post-COVID-19 immunization mucocutaneous reactions. To achieve this goal, a comprehensive electronic search was performed through the international databases including Medline (PubMed), Scopus, Cochrane, Web of science, and Google scholar on July 12, 2021, and all articles regarding mucocutaneous manifestations and considerations after COVID-19 vaccine administration were retrieved using the following keywords: COVID-19 vaccine, dermatology considerations and mucocutaneous manifestations. A total of 917 records were retrieved and a final number of 180 articles were included in data extraction. Read More

View Article and Full-Text PDF

Epidemiology of dermatomycoses in children in Northern Mato Grosso 2015-2020.

Mycoses 2022 May 31;65(5):560-566. Epub 2022 Mar 31.

Instituto de Ciências da Saúde, Universidade Federal de Mato Grosso, Sinop, Brazil.

Objectives: Dermatomycoses, fungal diseases that affect the superficial layers of skin, hair or nails, are a public health concern due to their high prevalence. In Brazil, dermatomycoses are not notifiable diseases, so only fragmented epidemiological studies have been reported in the national literature. To evaluate the epidemiological profile of dermatomycoses in preschoolers and school children in Sinop, Mato Grosso (MT), Brazil. Read More

View Article and Full-Text PDF

Reduction in new pityriasis rosea diagnoses during the COVID-19 pandemic: Evidence in support of a viral etiology.

JAAD Int 2022 Jun 17;7:124-125. Epub 2022 Mar 17.

Department of Dermatology, George Washington University, Washington, District of Columbia.

View Article and Full-Text PDF

Pityriasis rubra pilaris in association with inactivated SARS-CoV-2 vaccine (CoronaVac).

Dermatol Ther 2022 Mar 16:e15455. Epub 2022 Mar 16.

Universidad Autónoma de Nuevo León, Hospital Universitario "Dr. José Eleuterio González", Dermatology Department, Monterrey, Nuevo León, Mexico.

View Article and Full-Text PDF

Differences between pediatric and adult atopic dermatitis.

Pediatr Dermatol 2022 Mar 16. Epub 2022 Mar 16.

Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.

Atopic dermatitis (AD) is a common disease with a broad spectrum of clinical manifestations. AD can manifest differently in adults than children. Core AD features are similar between children and adults overall, including lesions affecting flexural areas, presence of atopy, and xerosis. Read More

View Article and Full-Text PDF

[Pityriasis rubra pilaris after COVID-19 vaccination: causal relationship or coincidence?]

Hautarzt 2022 Mar 16. Epub 2022 Mar 16.

Zentrum für Dermatologie, Allergologie und Dermatochirurgie, Helios Universitätsklinikum Wuppertal, Universität Witten/Herdecke, Heusnerstr. 40, 42283, Wuppertal, Deutschland.

Numerous cutaneous side effects associated with COVID-19 vaccines have been described since their clinical approval. These include, among others, injection site reactions, urticarial, maculopapular and pityriasiform rashes or temporary exacerbations of a pre-existing chronic inflammatory skin disease. Herein we report about three cases of pityriasis rubra pilaris that occurred for the first time in close temporal relationship with the administration of a COVID-19 vaccine. Read More

View Article and Full-Text PDF

The first case report of Pityriasis lichenoides chronica following COVID-19 mRNA vaccination.

Dermatol Ther 2022 Mar 14:e15445. Epub 2022 Mar 14.

Department of Pathology, Faculty of Medicine, Menoufia University, Shibin Al Kawm, Egypt.

View Article and Full-Text PDF

A Cross-Sectional Evaluation of the Usefulness of the Minor Features of Hanifin and Rajka Diagnostic Criteria for the Diagnosis of Atopic Dermatitis in the Pediatric Population.

Indian J Dermatol 2021 Nov-Dec;66(6):583-590

Department of Paediatric Dermatology, ICH, Kolkata, West Bengal, India.

Background: Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease. Hanifin and Rajka's criteria is the most common diagnostic criteria used for the clinical diagnosis of this condition. However, many find that it is too exhaustive to be used in routine practice, and the specificity of many of the minor criteria poses challenges, particularly from Asian countries with type III, IV, and V skin. Read More

View Article and Full-Text PDF

Difficulties in diagnosing Malassezia furfur bloodstream infection and possibility of spontaneous resolution in a patient undergoing chemotherapy for neuroblastoma: A case report.

J Infect Chemother 2022 Jul 9;28(7):987-990. Epub 2022 Mar 9.

Department of Infectious Diseases, Nagoya University Hospital, Aichi, Japan; Department of Infectious Diseases, Nagoya University Graduate School of Medicine, Aichi, Japan.

Malassezia furfur is a lipophilic, yeast-like fungus that forms part of the normal human skin microflora and is associated with a wide range of infections, such as pityriasis versicolor, folliculitis, and systemic infections in immunocompromised patients. Although matrix-assisted laser desorption/ionization time-of-flight mass spectrometry has enabled rapid identification of Malassezia species, it is still a challenge to diagnose systemic infections because Malassezia fungemia can often be missed by automated blood culture systems. We report a case in which M. Read More

View Article and Full-Text PDF